Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.91 on 11-09-2025 at 18:20:05
Change $-0.006 -0.66%
Buy $0.914
Sell $0.91
Last Trade: Sell 8,788.00 at $0.91
Day's Volume: 600,683
Last Close: $0.91
Open: $0.914
ISIN: GB00BDGKMY29
Day's Range $0.91 - $0.916
52wk Range: $0.80 - $0.93
Market Capitalisation: $1.03b
VWAP: $0.913002
Shares in Issue: 1.13b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 8,788 $0.91 Automatic Execution
16:36:19 - 11-Sep-25
Sell* 1,240 $0.91 Automatic Execution
16:36:19 - 11-Sep-25
Sell* 36,737 $0.91 Automatic Execution
16:36:19 - 11-Sep-25
Sell* 15,030 $0.91 Uncrossing Trade
16:35:19 - 11-Sep-25
Buy* 4,921 $0.914 Automatic Execution
16:29:13 - 11-Sep-25
Buy* 1,654 $0.914 Automatic Execution
16:29:07 - 11-Sep-25
Buy* 8,108 $0.914 Automatic Execution
16:27:03 - 11-Sep-25
Buy* 2,449 $0.914 Automatic Execution
16:24:45 - 11-Sep-25
Sell* 2,082 $0.91 Ordinary
16:23:12 - 11-Sep-25
Unknown* 2,082 $0.91 OTC Trade
16:23:12 - 11-Sep-25
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Sep 2025 (Thu) 0.914 0.916 0.91 0.91 600,683
10th Sep 2025 (Wed) 0.916 0.918 0.916 0.916 428,483
9th Sep 2025 (Tue) 0.918 0.92 0.91 0.916 672,737
8th Sep 2025 (Mon) 0.918 0.922 0.914 0.914 940,299
5th Sep 2025 (Fri) 0.912 0.93 0.91 0.928 2,185,907
4th Sep 2025 (Thu) 0.89 0.914 0.89 0.912 7,463,119
3rd Sep 2025 (Wed) 0.896 0.904 0.896 0.902 950,361
2nd Sep 2025 (Tue) 0.906 0.906 0.89 0.896 630,224
1st Sep 2025 (Mon) 0.91 0.91 0.898 0.898 798,008
29th Aug 2025 (Fri) 0.906 0.906 0.90 0.90 333,646
28th Aug 2025 (Thu) 0.902 0.906 0.90 0.90 582,377
27th Aug 2025 (Wed) 0.90 0.91 0.898 0.902 1,602,223
26th Aug 2025 (Tue) 0.91 0.91 0.902 0.902 706,918
25th Aug 2025 (Mon) 0.90 0.90 0.90 0.90 0
22nd Aug 2025 (Fri) 0.886 0.91 0.886 0.90 625,182
21st Aug 2025 (Thu) 0.904 0.908 0.89 0.896 1,146,083
20th Aug 2025 (Wed) 0.888 0.896 0.886 0.89 2,082,040
19th Aug 2025 (Tue) 0.882 0.892 0.882 0.888 649,079
18th Aug 2025 (Mon) 0.894 0.894 0.886 0.886 302,216
15th Aug 2025 (Fri) 0.896 0.902 0.888 0.888 1,428,776
14th Aug 2025 (Thu) 0.888 0.90 0.886 0.886 369,770
13th Aug 2025 (Wed) 0.888 0.892 0.88 0.884 1,486,833
12th Aug 2025 (Tue) 0.862 0.88 0.86 0.874 1,544,638
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
3rd Sep 2025 12:21 pm RNS NEW INVESTMENT OF UP TO US$62.5 MILLION
1st Sep 2025 2:26 pm RNS Total Voting Rights
26th Aug 2025 7:00 am RNS Notice of Half Year Results
22nd Aug 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Aug 2025 12:07 pm RNS Transaction in Own Shares - Correction
20th Aug 2025 6:16 pm RNS Transaction in Own Shares
12th Aug 2025 5:39 pm RNS Director/PDMR Shareholding
31st Jul 2025 7:00 am RNS Appointment of New Director
21st Jul 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
18th Jul 2025 4:23 pm RNS Holding(s) in Company
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

Burberry, recently debuted Metlen Energy & Metals to join FTSE 100

3rd Sep 2025 19:40

(Alliance News) - Burberry Group PLC and Metlen Energy & Metals PLC have been promoted to the FTSE 100 in its latest quarterly shuffle, with Taylor Wimpey PLC and Unite Group PLC relegated from the benchmark index. Read More

BioPharma Credit lends USD62.5 million to HPV treatment firm Precigen

3rd Sep 2025 13:51

(Alliance News) - BioPharma Credit PLC on Wednesday said it has agreed a senior secured loan with Precigen Inc to lend up to USD62.5 million. Read More

Metlen Energy set for FTSE 100, replacing Taylor Wimpey - FTSE Russell

26th Aug 2025 17:29

(Alliance News) - Metlen Energy & Metals PLC is set to join the FTSE 100 at the first time of asking, at the expense of housebuilder Taylor Wimpey PLC, data from FTSE Russell suggested on Tuesday. Read More

UK dividends calendar - next 7 days

24th Jul 2025 13:48

Read More

IN BRIEF: BioPharma Credit to be repaid following disposal by BioCryst

1st Jul 2025 14:20

BioPharma Credit PLC - London-based closed-ended investment company focused on the life sciences industry - Investment Manager Pharmakon Advisors LP notes that BioCryst Pharmaceuticals Inc has agreed to sell its European Orladeyo, or berotralsat, business to Neopharmed Gentili for up to USD264 million. Orladeyo is a treatment to prevent attacks of hereditary angioedema in adults and children 12 years of age and older. BioCryst expects to complete the disposal by early October, and intends to use the proceeds to repay its remaining USD248.7 million term debt. This includes the repayment of USD99.5 million owed to BioPharma. Under the terms of its senior secured loan deal with BioCryst, which was initially agreed in April 2023, BioPharma expects to receive a prepayment premium of 3% to the principal repaid. Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value9,297.58
Change72.19

Login to your account

Forgot Password?

Not Registered